Cybin Inc. (OTCMKTS:CLXPF – Get Free Report) reached a new 52-week high during mid-day trading on Thursday . The company traded as high as $11.52 and last traded at $11.40, with a volume of 395431 shares trading hands. The stock had previously closed at $9.94.
Cybin Price Performance
The stock has a market capitalization of $1.60 billion and a price-to-earnings ratio of -44.92. The stock’s 50 day simple moving average is $7.20 and its 200-day simple moving average is $2.70.
About Cybin
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
Read More
- Five stocks we like better than Cybin
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
- What is a support level?
- MarketBeat Week in Review – 11/4 – 11/8
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Trump’s Return: Which Sectors Will Benefit Most?
Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.
